Ligand Pharmaceuticals Revenue and Competitors

Location

$875M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Ligand Pharmaceuticals's estimated annual revenue is currently $21.2M per year.(i)
  • Ligand Pharmaceuticals's estimated revenue per employee is $155,000
  • Ligand Pharmaceuticals's total funding is $875M.

Employee Data

  • Ligand Pharmaceuticals has 137 Employees.(i)
  • Ligand Pharmaceuticals grew their employee count by -14% last year.

Ligand Pharmaceuticals's People

NameTitleEmail/Phone
1
Assistant General Counsel & Chief Patent CounselReveal Email/Phone
2
VP, Chemistry & Pharmaceutical SciencesReveal Email/Phone
3
SVP, Biology & Scientific AffairsReveal Email/Phone
4
SVP, Investments and Business DevelopmentReveal Email/Phone
5
VP, Protein SciencesReveal Email/Phone
6
VP, Corporate ControllerReveal Email/Phone
7
VP, New Product DevelopmentReveal Email/Phone
8
VP, Protein SciencesReveal Email/Phone
9
SVP, Technical Operations and QAReveal Email/Phone
10
SVP Clinical Strategy and InvestmentsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Ligand Pharmaceuticals?

Ligand Pharmaceuticals is a royalty-driven biotechnology company with strong research and drug discovery capabilities. We have numerous valuable corporate partnerships, a broad product pipeline targeting large markets, proven scientific credentials in combination with partners and a strong balance sheet.

keywords:N/A

$875M

Total Funding

137

Number of Employees

$21.2M

Revenue (est)

-14%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ligand Pharmaceuticals News

2022-04-20 - Narcolepsy Drugs Market Size, Scope And Outlook | Ligand ...

Ligand Pharmaceuticals, Addrenex Pharmaceuticals, Shire Plc, Teva Pharmaceutical Industries Ltd., Arena Pharmaceuticals,...

2022-04-19 - Ligand Pharmaceuticals (LGND) Set to Announce Quarterly ...

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical...

2022-03-30 - Ligand Pharmaceuticals Announces Inducement Grant Under ...

Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop...

2019-07-24 - Ligand Pharmaceuticals Acquires Ab Initio Biotherapeutics, for $12M

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) acquired Ab Initio Biotherapeutics, an antigen-discovery company based in South San Francisco, California, for $12m. Ab Initio brings to Ligand patented antigen technology that is synergistic with its OmniAb® therapeutic antibody discovery plat ...

2018-08-09 - Ligand to Acquire Drug Discovery Company Vernalis, For $43M

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), a San Diego, CA-based biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines, is to acquire Vernalis plc (LSE: VER), a structure-based drug discovery biotechno ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16.4M137-4%N/A
#2
$28.8M13714%N/A
#3
$19.9M13710%N/A
#4
$19.9M13710%N/A
#5
$27.5M137-4%N/A